In the Peters lab, we are using the power of bacterial genetics to address critical issues in the bioeconomy and antimicrobial resistance. Our CRISPR-based functional genomics approaches will allow us to define the roles of gene networks in the process of using microbes to convert plant material into valuable biofuels and bioproducts as well as in antibiotic targeting and resistance. We are currently developing innovative CRISPR tools for exploration of gene function in bioenergy-relevant alpha-Proteobacteria (e.g., Zymomonas mobilis) and antibiotic resistant ESKAPE pathogens (e.g., Acinetobacter baumannii).
School of Pharmacy Assessment Committee
Microbiology Doctoral Training Program Steering Committee
Genetics Steering Committee
Education:
BS Biology - Southeast Missouri State University
BS Secondary Education - Southeast Missouri State University
PhD Genetics - University of Wisconsin-Madison with Robert Landick
Postdoctoral studies - University of California, San Francisco with Carol Gross
PHARMACY 434 — Pharmaceutical Genetics and Immunology (Course Coordinator)
PHM SCI 522 — Pharmacology II
PHM SCI 780 — Principles of Pharmaceutical Sciences
MICROBIO 612 — Prokaryotic Molecular Biology
PHM SCI 645 — Pharmaceutical Biotechnology & Pharmacogenomics
